A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-10-19) →
What happened
Remed disclosed convertible bonds to raise US$7.46M, about 12.6% of its market value.
For context, this raise equals about 12.6% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$7.46M |
| vs. market value | 12.6% |
| Filed | 2026-10-14, Material event report (convertible bonds) |
| Source | DART rcept 20261014000424 → open original filing |
Versions of this filing
- 2026-10-14Original (this page)
- 2026-10-19Amendment 1
Source: DART. Information only, not investment advice.